Insufficient scRNA-seq data for expression of MORC1 at single-cell level.
Insufficient scRNA-seq data for expression of MORC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 62% | 20.29 | 13 / 21 | 2% | 0.06 | 8 / 504 |
| brain | 49% | 8.68 | 1289 / 2642 | 9% | 0.14 | 64 / 705 |
| ovary | 56% | 12.70 | 100 / 180 | 0% | 0.04 | 2 / 430 |
| spleen | 50% | 5.52 | 121 / 241 | 0% | 0 | 0 / 0 |
| prostate | 42% | 5.18 | 102 / 245 | 1% | 0.05 | 6 / 502 |
| liver | 36% | 5.23 | 81 / 226 | 1% | 0.06 | 4 / 406 |
| adrenal gland | 21% | 2.02 | 55 / 258 | 4% | 0.15 | 10 / 230 |
| intestine | 23% | 2.00 | 220 / 966 | 0% | 0.02 | 2 / 527 |
| skin | 4% | 0.25 | 64 / 1809 | 19% | 1.16 | 89 / 472 |
| kidney | 20% | 1.60 | 18 / 89 | 0% | 0.01 | 2 / 901 |
| adipose | 16% | 1.01 | 195 / 1204 | 0% | 0 | 0 / 0 |
| lung | 13% | 0.87 | 73 / 578 | 4% | 0.29 | 41 / 1155 |
| peripheral blood | 15% | 0.94 | 138 / 929 | 0% | 0 | 0 / 0 |
| stomach | 13% | 0.73 | 46 / 359 | 2% | 0.18 | 5 / 286 |
| breast | 14% | 1.14 | 62 / 459 | 1% | 0.04 | 11 / 1118 |
| pancreas | 10% | 0.49 | 33 / 328 | 0% | 0 | 0 / 178 |
| uterus | 8% | 0.92 | 13 / 170 | 1% | 0.02 | 3 / 459 |
| blood vessel | 7% | 0.42 | 96 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 7% | 1.32 | 45 / 653 | 0% | 0 | 0 / 605 |
| esophagus | 5% | 0.37 | 68 / 1445 | 2% | 0.04 | 3 / 183 |
| heart | 2% | 0.10 | 16 / 861 | 0% | 0 | 0 / 0 |
| muscle | 1% | 0.18 | 10 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001662 | Biological process | behavioral fear response |
| GO_0032197 | Biological process | retrotransposition |
| GO_2000143 | Biological process | negative regulation of DNA-templated transcription initiation |
| GO_0141005 | Biological process | retrotransposon silencing by heterochromatin formation |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0030154 | Biological process | cell differentiation |
| GO_0031047 | Biological process | regulatory ncRNA-mediated gene silencing |
| GO_0044727 | Biological process | epigenetic programing of male pronucleus |
| GO_0001673 | Cellular component | male germ cell nucleus |
| GO_0005634 | Cellular component | nucleus |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | MORC1 |
| Protein name | MORC family CW-type zinc finger protein 1 (Cancer/testis antigen 33) (CT33) |
| Synonyms | MORC |
| Description | FUNCTION: Required for spermatogenesis (By similarity). Essential for de novo DNA methylation and silencing of transposable elements in the male embryonic germ cells (By similarity). . |
| Accessions | ENST00000483760.1 [Q86VD1-2] ENST00000232603.10 [Q86VD1-1] Q86VD1 |